The new presidential administration in the United States could significantly impact MedTech and pharmaceutical regulations for manufacturers and product developers. In this webinar our expert panel of scientists and FDA consultants will explore the potential regulatory changes. The presenters will discuss changes in several key areas, including FDA policy shifts, warning and consent letters, vaccine regulation, artificial intelligence (AI) in healthcare, and the supply chain. They will also share firsthand knowledge of ongoing discussions and emerging trends and help you prepare for changes that will shape the future of the healthcare industry.
Attend this webinar and learn about the following:
- What regulatory changes could be coming in 2025
- FDA focal points in the new administration
- Potential impact to the MedTech and Pharm industries
Learn more about the presenters below.